MO
44
-3
PM
47
-2
MCHP
36
3
ES
26
14
MDLZ
30
2
O
20
-6
BIIB
39
2
CVX
14
-11
LUV
48
3
EBAY
39
-3
BMY
38
-3
R
59
4
PAYX
39
3
GS
55
-10
NWSA
71
2
QRVO
18
2
AMG
49
14
AON
28
2
MOS
38
2
VRTX
47
2
MO
44
-3
PM
47
-2
MCHP
36
3
ES
26
14
MDLZ
30
2
O
20
-6
BIIB
39
2
CVX
14
-11
LUV
48
3
EBAY
39
-3
BMY
38
-3
R
59
4
PAYX
39
3
GS
55
-10
NWSA
71
2
QRVO
18
2
AMG
49
14
AON
28
2
MOS
38
2
VRTX
47
2
Financhill
Back

Beiersdorf AG 10K Form

Sell
39

BDRFY
Beiersdorf AG

Last Price:
$25.67
Seasonality Move:
-1.27%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BDRFY News And Ratings

See the #1 stock for the next 7 days that we like better than BDRFY

BDRFY Financial Statistics

Sales & Book Value

Annual Sales: $10.2B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $8.03
Price / Book: 3.23

Profitability

EPS (TTM): 0.69990
Net Income (TTM): $794.7M
Gross Margin: $5.9B
Return on Equity: 8.78%
Return on Assets: 5.64%

Beiersdorf AG Earnings Forecast

Key Beiersdorf AG Financial Ratios

  • The Gross Profit Margin over the past 22 years for BDRFY is 57.33%.
  • The Selling, General & Administrative Expenses for BDRFY have been equal to 40.44% of Gross Profit Margin.
  • The Research & Development expenses have been 3.39% of Revenue.
  • The Interest Expense is 3.53% of Operating Income.
  • The Net Earning history of BDRFY is 7.79% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 11 years.

Beiersdorf AG Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Personal Care Products
Sector: Consumer Staples
Current Symbol: BDRFY
Website: beiersdorf.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.69
Quick Ratio: 1.26

Price-to-Earnings

Trailing P/E Ratio: 36.65
Forward P/E Ratio: 0

BDRFY Technical Analysis vs Fundamental Analysis

Sell
39
Beiersdorf AG (BDRFY) is a Sell

Is Beiersdorf AG a Buy or a Sell?

  • Beiersdorf AG stock is rated a Sell
    The current Beiersdorf AG [BDRFY] share price is $25.71. The Score for BDRFY is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.